Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Innovative Treatment for Venous Reflux Disease

By HospiMedica International staff writers
Posted on 13 Apr 2009
A minimally invasive procedure for patients suffering with symptomatic varicose veins and venous reflux offers advantages over conventional vein stripping surgery.

The VNUS Closure procedure consists of inserting a thin radiofrequency (RF) catheter into the diseased vein through a small incision. More...
The catheter then heats the diseased vein sequentially in 7-cm segments, sealing it from the inside and effectively closing it down; blood returning to the heart then naturally reroutes through healthy veins that contain normal valves. The system includes an integrated cable and a streamlined hub designed for easier use and better ergonomics. The device delivers the RF energy via two bipolar electrodes at the distal tip of the rigid shaft, heating the vein wall and creating the vein wall thickening and occlusion. A micro-thermocouple monitors temperature and provides continuous feedback to the physician. The ablation procedure can be performed either as a primary outpatient procedure or as an adjunct to saphenous vein ablation procedures. The VNUS Closure procedure was developed by VNUS Medical Technologies (San Jose, CA, USA).

"In my view the VNUS Closure procedure is the preferred technique to treat venous reflux because it requires no special modifications to operating areas, is well tolerated by patients, requires minimal postprocedure analgesia and is highly effective at permanently closing the vein," said Ian Franklin, a consultant vascular surgeon from the Imperial College London Charing Cross NHS Hospital (London, United Kingdom), commenting on the announcement by the UK National Health Service (NHS) National Innovation Center that identified the VNUS Closure procedure as a select innovative technology that is bringing benefits to NHS hospitals and patients.

"Our treatment alternative has enabled many NHS Trusts to perform a very common operation virtually pain-free in a simple treatment room in around 30-40 minutes without a general anesthetic or overnight stay," responded Michael Branagan-Harris, UK managing director for VNUS Medical Technologies. "This in turn has enabled hospitals to save money by freeing up expensive resources such as operating theatres, ward beds and staff for more invasive procedures."

Varicose veins are caused by increased pressure in the legs as a result of venous reflux and faulty valves in the leg veins. Left untreated, venous reflux can lead to painful varicose veins, swelling in the lower limbs, and skin problems, such as itching, redness, eczema, and leg ulcers.

Related Links:

VNUS Medical Technologies
Imperial College London Charing Cross NHS Hospital



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
ow Frequency Pulse Massager
ET10 L
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.